MedPath

Evaluation of the Effect of Date Cream in the Treatment of Eczema

Phase 3
Recruiting
Conditions
L20.84
Intrinsic (allergic) eczema
Eczema disease.
Registration Number
IRCT20211127053186N1
Lead Sponsor
Tehran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
50
Inclusion Criteria

Patients with mild to moderate eczema may be eligible for admission

Exclusion Criteria

People who have underlying diseases.
People who very old and difficult to get information from them.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
itching rate. Timepoint: Periods include assessing the amount of pruritus before and after treatment for two weeks. Method of measurement: standard skin questionnaire.;The rate of inflammation. Timepoint: Periods include assessing the extent of inflammation before and after treatment for two weeks. Method of measurement: a questionnaire.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath